| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.8 |